Lunit SCOPE Demonstrates High Concordance with Pathologists in HER2 Interpretation for Advanced Biliary Tract Cancer
PR Newswire —
Study published in Laboratory Investigation, the official journal of the United States and Canadian Academy of Pathology SEOUL, South Korea, Dec. 23, 2025 /PRNewswire/ -- Lunit (KRX: 328130) , a leading provider of AI for cancer diagnostics and precision oncology, today announced that a...